1
/
의
1
AntibodySystem
SKU(재고 관리 코드):KAV00102
Anti-SARS-CoV-2 Spike Protein (Beta/B.1.351) Human IgG ELISA Kit
Anti-SARS-CoV-2 Spike Protein (Beta/B.1.351) Human IgG ELISA Kit
Catalog No.: KAV00102
| Catalog No. | KAV00102 |
|---|---|
| Product name | Anti-SARS-CoV-2 Spike Protein (Beta/B.1.351) Human IgG ELISA Kit |
| Size | 96 T |
| Description | PRINCIPLE OF THE ASSAY This assay employs the quantitative indirect enzyme immunoassay technique. Recombinant SARS-CoV-2 Spike Protein (Beta/B.1.351) has been pre-coated onto a microplate. Standards or samples are pipetted into the wells and any Anti-SARS-CoV-2 Spike Protein (Beta/B.1.351) Human IgG present is bound by the immobilized protein. After washing away any unbound substances, a HRP-labeled Goat Anti-Human IgG antibody is added to the wells. Following a wash to remove any unbound enzyme reagent, a substrate solution is added to the wells and color develops in proportion to the amount of Anti-SARS-CoV-2 Spike Protein (Beta/B.1.351) Human IgG bound in the initial step. The color development is stopped and the intensity of the color is measured. |
| Applications | Used for the quantitative determination of Anti-SARS-CoV-2 Spike Protein (Beta/B.1.351) Human IgG concentration in serum and plasma. |
| Stability and Storage | The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition. |
| Detection method | Colorimetric |
| Precision | CV<15% |
| Sample type | Plasma, Serum |
| Assay type | Quantitative |
| Sensitivity | 0.47 ng/mL |
| Range | 1.56 - 100 ng/mL |
| Recovery | 80-120% |
| Shipping | 2-8 ℃ |
| Note | For Research Use Only. |
Share
